Global Active Pharmaceutical Ingredient Market Professional Survey Report 2017
- QYR2148979
- 123 Pages
- October 2017
- Pharmaceuticals
This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
Teva
Novartis
Pfizer
Johnson & Johnson
Mylan
North China Pharmaceutical Group
Dr. Reddy’s Laboratories
Roche
Aurobindo pharma
Sun Pharmaceutical Industries
Boehringer Ingelheim GmbH
Bayer
BASF
DSM
Zhejiang Medicine
Biocon
Johnson Matthey
Hisun Pharmacy
Cambrex
Shandong Xinhua Pharmaceutical
Lonza group
Huahai Pharmaceutical
Haerbin Pharmaceutical Group
Cipla
Tian Yao
Lupin
North East Pharmaceutical
Albemarle
Shandong Lukang Pharmaceutical
Jiangsu?Hengrui Medicine
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Synthetic API
Biotech API
Other
By Application, the market can be split into
Chemical
Deodorant
Dailylife
By Regions, this report covers (we can add the regions/countries as you want)
North America
China
Europe
Southeast Asia
Japan
India
If you have any special requirements, please let us know and we will offer you the report as you want.
Global Active Pharmaceutical Ingredient Market Professional Survey Report 2017
1 Industry Overview of Active Pharmaceutical Ingredient
1.1 Definition and Specifications of Active Pharmaceutical Ingredient
1.1.1 Definition of Active Pharmaceutical Ingredient
1.1.2 Specifications of Active Pharmaceutical Ingredient
1.2 Classification of Active Pharmaceutical Ingredient
1.2.1 Synthetic API
1.2.2 Biotech API
1.2.3 Other
1.3 Applications of Active Pharmaceutical Ingredient
1.3.1 Chemical
1.3.2 Deodorant
1.3.3 Dailylife
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 China
1.4.3 Europe
1.4.4 Southeast Asia
1.4.5 Japan
1.4.6 India
2 Manufacturing Cost Structure Analysis of Active Pharmaceutical Ingredient
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Active Pharmaceutical Ingredient
2.3 Manufacturing Process Analysis of Active Pharmaceutical Ingredient
2.4 Industry Chain Structure of Active Pharmaceutical Ingredient
3 Technical Data and Manufacturing Plants Analysis of Active Pharmaceutical Ingredient
3.1 Capacity and Commercial Production Date of Global Active Pharmaceutical Ingredient Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global Active Pharmaceutical Ingredient Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global Active Pharmaceutical Ingredient Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global Active Pharmaceutical Ingredient Major Manufacturers in 2016
4 Global Active Pharmaceutical Ingredient Overall Market Overview
4.1 2012-2017E Overall Market Analysis
4.2 Capacity Analysis
4.2.1 2012-2017E Global Active Pharmaceutical Ingredient Capacity and Growth Rate Analysis
4.2.2 2016 Active Pharmaceutical Ingredient Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2012-2017E Global Active Pharmaceutical Ingredient Sales and Growth Rate Analysis
4.3.2 2016 Active Pharmaceutical Ingredient Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2012-2017E Global Active Pharmaceutical Ingredient Sales Price
4.4.2 2016 Active Pharmaceutical Ingredient Sales Price Analysis (Company Segment)
5 Active Pharmaceutical Ingredient Regional Market Analysis
5.1 North America Active Pharmaceutical Ingredient Market Analysis
5.1.1 North America Active Pharmaceutical Ingredient Market Overview
5.1.2 North America 2012-2017E Active Pharmaceutical Ingredient Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America 2012-2017E Active Pharmaceutical Ingredient Sales Price Analysis
5.1.4 North America 2016 Active Pharmaceutical Ingredient Market Share Analysis
5.2 China Active Pharmaceutical Ingredient Market Analysis
5.2.1 China Active Pharmaceutical Ingredient Market Overview
5.2.2 China 2012-2017E Active Pharmaceutical Ingredient Local Supply, Import, Export, Local Consumption Analysis
5.2.3 China 2012-2017E Active Pharmaceutical Ingredient Sales Price Analysis
5.2.4 China 2016 Active Pharmaceutical Ingredient Market Share Analysis
5.3 Europe Active Pharmaceutical Ingredient Market Analysis
5.3.1 Europe Active Pharmaceutical Ingredient Market Overview
5.3.2 Europe 2012-2017E Active Pharmaceutical Ingredient Local Supply, Import, Export, Local Consumption Analysis
5.3.3 Europe 2012-2017E Active Pharmaceutical Ingredient Sales Price Analysis
5.3.4 Europe 2016 Active Pharmaceutical Ingredient Market Share Analysis
5.4 Southeast Asia Active Pharmaceutical Ingredient Market Analysis
5.4.1 Southeast Asia Active Pharmaceutical Ingredient Market Overview
5.4.2 Southeast Asia 2012-2017E Active Pharmaceutical Ingredient Local Supply, Import, Export, Local Consumption Analysis
5.4.3 Southeast Asia 2012-2017E Active Pharmaceutical Ingredient Sales Price Analysis
5.4.4 Southeast Asia 2016 Active Pharmaceutical Ingredient Market Share Analysis
5.5 Japan Active Pharmaceutical Ingredient Market Analysis
5.5.1 Japan Active Pharmaceutical Ingredient Market Overview
5.5.2 Japan 2012-2017E Active Pharmaceutical Ingredient Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Japan 2012-2017E Active Pharmaceutical Ingredient Sales Price Analysis
5.5.4 Japan 2016 Active Pharmaceutical Ingredient Market Share Analysis
5.6 India Active Pharmaceutical Ingredient Market Analysis
5.6.1 India Active Pharmaceutical Ingredient Market Overview
5.6.2 India 2012-2017E Active Pharmaceutical Ingredient Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India 2012-2017E Active Pharmaceutical Ingredient Sales Price Analysis
5.6.4 India 2016 Active Pharmaceutical Ingredient Market Share Analysis
6 Global 2012-2017E Active Pharmaceutical Ingredient Segment Market Analysis (by Type)
6.1 Global 2012-2017E Active Pharmaceutical Ingredient Sales by Type
6.2 Different Types of Active Pharmaceutical Ingredient Product Interview Price Analysis
6.3 Different Types of Active Pharmaceutical Ingredient Product Driving Factors Analysis
6.3.1 Synthetic API of Active Pharmaceutical Ingredient Growth Driving Factor Analysis
6.3.2 Biotech API of Active Pharmaceutical Ingredient Growth Driving Factor Analysis
6.3.3 Other of Active Pharmaceutical Ingredient Growth Driving Factor Analysis
7 Global 2012-2017E Active Pharmaceutical Ingredient Segment Market Analysis (by Application)
7.1 Global 2012-2017E Active Pharmaceutical Ingredient Consumption by Application
7.2 Different Application of Active Pharmaceutical Ingredient Product Interview Price Analysis
7.3 Different Application of Active Pharmaceutical Ingredient Product Driving Factors Analysis
7.3.1 Chemical of Active Pharmaceutical Ingredient Growth Driving Factor Analysis
7.3.2 Deodorant of Active Pharmaceutical Ingredient Growth Driving Factor Analysis
7.3.3 Dailylife of Active Pharmaceutical Ingredient Growth Driving Factor Analysis
8 Major Manufacturers Analysis of Active Pharmaceutical Ingredient
8.1 Teva
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.2.1 Product A
8.1.2.2 Product B
8.1.3 Teva 2016 Active Pharmaceutical Ingredient Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 Teva 2016 Active Pharmaceutical Ingredient Business Region Distribution Analysis
8.2 Novartis
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.2.1 Product A
8.2.2.2 Product B
8.2.3 Novartis 2016 Active Pharmaceutical Ingredient Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Novartis 2016 Active Pharmaceutical Ingredient Business Region Distribution Analysis
8.3 Pfizer
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.2.1 Product A
8.3.2.2 Product B
8.3.3 Pfizer 2016 Active Pharmaceutical Ingredient Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Pfizer 2016 Active Pharmaceutical Ingredient Business Region Distribution Analysis
8.4 Johnson & Johnson
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.2.1 Product A
8.4.2.2 Product B
8.4.3 Johnson & Johnson 2016 Active Pharmaceutical Ingredient Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Johnson & Johnson 2016 Active Pharmaceutical Ingredient Business Region Distribution Analysis
8.5 Mylan
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.2.1 Product A
8.5.2.2 Product B
8.5.3 Mylan 2016 Active Pharmaceutical Ingredient Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 Mylan 2016 Active Pharmaceutical Ingredient Business Region Distribution Analysis
8.6 North China Pharmaceutical Group
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.2.1 Product A
8.6.2.2 Product B
8.6.3 North China Pharmaceutical Group 2016 Active Pharmaceutical Ingredient Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 North China Pharmaceutical Group 2016 Active Pharmaceutical Ingredient Business Region Distribution Analysis
8.7 Dr. Reddy’s Laboratories
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.2.1 Product A
8.7.2.2 Product B
8.7.3 Dr. Reddy’s Laboratories 2016 Active Pharmaceutical Ingredient Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Dr. Reddy’s Laboratories 2016 Active Pharmaceutical Ingredient Business Region Distribution Analysis
8.8 Roche
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.2.1 Product A
8.8.2.2 Product B
8.8.3 Roche 2016 Active Pharmaceutical Ingredient Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 Roche 2016 Active Pharmaceutical Ingredient Business Region Distribution Analysis
8.9 Aurobindo pharma
8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.2.1 Product A
8.9.2.2 Product B
8.9.3 Aurobindo pharma 2016 Active Pharmaceutical Ingredient Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.9.4 Aurobindo pharma 2016 Active Pharmaceutical Ingredient Business Region Distribution Analysis
8.10 Sun Pharmaceutical Industries
8.10.1 Company Profile
8.10.2 Product Picture and Specifications
8.10.2.1 Product A
8.10.2.2 Product B
8.10.3 Sun Pharmaceutical Industries 2016 Active Pharmaceutical Ingredient Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.10.4 Sun Pharmaceutical Industries 2016 Active Pharmaceutical Ingredient Business Region Distribution Analysis
8.11 Boehringer Ingelheim GmbH
8.12 Bayer
8.13 BASF
8.14 DSM
8.15 Zhejiang Medicine
8.16 Biocon
8.17 Johnson Matthey
8.18 Hisun Pharmacy
8.19 Cambrex
8.20 Shandong Xinhua Pharmaceutical
8.21 Lonza group
8.22 Huahai Pharmaceutical
8.23 Haerbin Pharmaceutical Group
8.24 Cipla
8.25 Tian Yao
8.26 Lupin
8.27 North East Pharmaceutical
8.28 Albemarle
8.29 Shandong Lukang Pharmaceutical
8.30 Jiangsu?Hengrui Medicine
9 Development Trend of Analysis of Active Pharmaceutical Ingredient Market
9.1 Global Active Pharmaceutical Ingredient Market Trend Analysis
9.1.1 Global 2017-2022 Active Pharmaceutical Ingredient Market Size (Volume and Value) Forecast
9.1.2 Global 2017-2022 Active Pharmaceutical Ingredient Sales Price Forecast
9.2 Active Pharmaceutical Ingredient Regional Market Trend
9.2.1 North America 2017-2022 Active Pharmaceutical Ingredient Consumption Forecast
9.2.2 China 2017-2022 Active Pharmaceutical Ingredient Consumption Forecast
9.2.3 Europe 2017-2022 Active Pharmaceutical Ingredient Consumption Forecast
9.2.4 Southeast Asia 2017-2022 Active Pharmaceutical Ingredient Consumption Forecast
9.2.5 Japan 2017-2022 Active Pharmaceutical Ingredient Consumption Forecast
9.2.6 India 2017-2022 Active Pharmaceutical Ingredient Consumption Forecast
9.3 Active Pharmaceutical Ingredient Market Trend (Product Type)
9.4 Active Pharmaceutical Ingredient Market Trend (Application)
10 Active Pharmaceutical Ingredient Marketing Type Analysis
10.1 Active Pharmaceutical Ingredient Regional Marketing Type Analysis
10.2 Active Pharmaceutical Ingredient International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Active Pharmaceutical Ingredient by Region
10.4 Active Pharmaceutical Ingredient Supply Chain Analysis
11 Consumers Analysis of Active Pharmaceutical Ingredient
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis
…
12 Conclusion of the Global Active Pharmaceutical Ingredient Market Professional Survey Report 2017
Methodology
Analyst Introduction
Data Source
Figure Picture of Active Pharmaceutical Ingredient
Table Product Specifications of Active Pharmaceutical Ingredient
Table Classification of Active Pharmaceutical Ingredient
Figure Global Production Market Share of Active Pharmaceutical Ingredient by Type in 2016
Figure Synthetic API Picture
Table Major Manufacturers of Synthetic API
Figure Biotech API Picture
Table Major Manufacturers of Biotech API
Figure Other Picture
Table Major Manufacturers of Other
Table Applications of Active Pharmaceutical Ingredient
Figure Global Consumption Volume Market Share of Active Pharmaceutical Ingredient by Application in 2016
Figure Chemical Examples
Table Major Consumers in Chemical
Figure Deodorant Examples
Table Major Consumers in Deodorant
Figure Dailylife Examples
Table Major Consumers in Dailylife
Figure Market Share of Active Pharmaceutical Ingredient by Regions
Figure North America Active Pharmaceutical Ingredient Market Size (Million USD) (2012-2022)
Figure China Active Pharmaceutical Ingredient Market Size (Million USD) (2012-2022)
Figure Europe Active Pharmaceutical Ingredient Market Size (Million USD) (2012-2022)
Figure Southeast Asia Active Pharmaceutical Ingredient Market Size (Million USD) (2012-2022)
Figure Japan Active Pharmaceutical Ingredient Market Size (Million USD) (2012-2022)
Figure India Active Pharmaceutical Ingredient Market Size (Million USD) (2012-2022)
Table Active Pharmaceutical Ingredient Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Active Pharmaceutical Ingredient in 2016
Figure Manufacturing Process Analysis of Active Pharmaceutical Ingredient
Figure Industry Chain Structure of Active Pharmaceutical Ingredient
Table Capacity and Commercial Production Date of Global Active Pharmaceutical Ingredient Major Manufacturers in 2016
Table Manufacturing Plants Distribution of Global Active Pharmaceutical Ingredient Major Manufacturers in 2016
Table R&D Status and Technology Source of Global Active Pharmaceutical Ingredient Major Manufacturers in 2016
Table Raw Materials Sources Analysis of Global Active Pharmaceutical Ingredient Major Manufacturers in 2016
Table Global Capacity, Sales , Price, Cost, Sales Revenue (M USD) and Gross Margin of Active Pharmaceutical Ingredient 2012-2017
Figure Global 2012-2017E Active Pharmaceutical Ingredient Market Size (Volume) and Growth Rate
Figure Global 2012-2017E Active Pharmaceutical Ingredient Market Size (Value) and Growth Rate
Table 2012-2017E Global Active Pharmaceutical Ingredient Capacity and Growth Rate
Table 2016 Global Active Pharmaceutical Ingredient Capacity (K MT) List (Company Segment)
Table 2012-2017E Global Active Pharmaceutical Ingredient Sales (K MT) and Growth Rate
Table 2016 Global Active Pharmaceutical Ingredient Sales (K MT) List (Company Segment)
Table 2012-2017E Global Active Pharmaceutical Ingredient Sales Price (USD/MT)
Table 2016 Global Active Pharmaceutical Ingredient Sales Price (USD/MT) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K MT) of Active Pharmaceutical Ingredient 2012-2017E
Figure North America 2012-2017E Active Pharmaceutical Ingredient Sales Price (USD/MT)
Figure North America 2016 Active Pharmaceutical Ingredient Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K MT) of Active Pharmaceutical Ingredient 2012-2017E
Figure China 2012-2017E Active Pharmaceutical Ingredient Sales Price (USD/MT)
Figure China 2016 Active Pharmaceutical Ingredient Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K MT) of Active Pharmaceutical Ingredient 2012-2017E
Figure Europe 2012-2017E Active Pharmaceutical Ingredient Sales Price (USD/MT)
Figure Europe 2016 Active Pharmaceutical Ingredient Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K MT) of Active Pharmaceutical Ingredient 2012-2017E
Figure Southeast Asia 2012-2017E Active Pharmaceutical Ingredient Sales Price (USD/MT)
Figure Southeast Asia 2016 Active Pharmaceutical Ingredient Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K MT) of Active Pharmaceutical Ingredient 2012-2017E
Figure Japan 2012-2017E Active Pharmaceutical Ingredient Sales Price (USD/MT)
Figure Japan 2016 Active Pharmaceutical Ingredient Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K MT) of Active Pharmaceutical Ingredient 2012-2017E
Figure India 2012-2017E Active Pharmaceutical Ingredient Sales Price (USD/MT)
Figure India 2016 Active Pharmaceutical Ingredient Sales Market Share
Table Global 2012-2017E Active Pharmaceutical Ingredient Sales (K MT) by Type
Table Different Types Active Pharmaceutical Ingredient Product Interview Price
Table Global 2012-2017E Active Pharmaceutical Ingredient Sales (K MT) by Application
Table Different Application Active Pharmaceutical Ingredient Product Interview Price
Table Teva Information List
Table Product A Overview
Table Product B Overview
Table 2016 Teva Active Pharmaceutical Ingredient Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 Teva Active Pharmaceutical Ingredient Business Region Distribution
Table Novartis Information List
Table Product A Overview
Table Product B Overview
Table 2016 Novartis Active Pharmaceutical Ingredient Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 Novartis Active Pharmaceutical Ingredient Business Region Distribution
Table Pfizer Information List
Table Product A Overview
Table Product B Overview
Table 2015 Pfizer Active Pharmaceutical Ingredient Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 Pfizer Active Pharmaceutical Ingredient Business Region Distribution
Table Johnson & Johnson Information List
Table Product A Overview
Table Product B Overview
Table 2016 Johnson & Johnson Active Pharmaceutical Ingredient Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 Johnson & Johnson Active Pharmaceutical Ingredient Business Region Distribution
Table Mylan Information List
Table Product A Overview
Table Product B Overview
Table 2016 Mylan Active Pharmaceutical Ingredient Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 Mylan Active Pharmaceutical Ingredient Business Region Distribution
Table North China Pharmaceutical Group Information List
Table Product A Overview
Table Product B Overview
Table 2016 North China Pharmaceutical Group Active Pharmaceutical Ingredient Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 North China Pharmaceutical Group Active Pharmaceutical Ingredient Business Region Distribution
Table Dr. Reddy’s Laboratories Information List
Table Product A Overview
Table Product B Overview
Table 2016 Dr. Reddy’s Laboratories Active Pharmaceutical Ingredient Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 Dr. Reddy’s Laboratories Active Pharmaceutical Ingredient Business Region Distribution
Table Roche Information List
Table Product A Overview
Table Product B Overview
Table 2016 Roche Active Pharmaceutical Ingredient Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 Roche Active Pharmaceutical Ingredient Business Region Distribution
Table Aurobindo pharma Information List
Table Product A Overview
Table Product B Overview
Table 2016 Aurobindo pharma Active Pharmaceutical Ingredient Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 Aurobindo pharma Active Pharmaceutical Ingredient Business Region Distribution
Table Sun Pharmaceutical Industries Information List
Table Product A Overview
Table Product B Overview
Table 2016 Sun Pharmaceutical Industries Active Pharmaceutical Ingredient Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 Sun Pharmaceutical Industries Active Pharmaceutical Ingredient Business Region Distribution
Table Boehringer Ingelheim GmbH Information List
Table Bayer Information List
Table BASF Information List
Table DSM Information List
Table Zhejiang Medicine Information List
Table Biocon Information List
Table Johnson Matthey Information List
Table Hisun Pharmacy Information List
Table Cambrex Information List
Table Shandong Xinhua Pharmaceutical Information List
Table Lonza group Information List
Table Huahai Pharmaceutical Information List
Table Haerbin Pharmaceutical Group Information List
Table Cipla Information List
Table Tian Yao Information List
Table Lupin Information List
Table North East Pharmaceutical Information List
Table Albemarle Information List
Table Shandong Lukang Pharmaceutical Information List
Table Jiangsu?Hengrui Medicine Information List
Figure Global 2017-2022 Active Pharmaceutical Ingredient Market Size (K MT) and Growth Rate Forecast
Figure Global 2017-2022 Active Pharmaceutical Ingredient Market Size (Million USD) and Growth Rate Forecast
Figure Global 2017-2022 Active Pharmaceutical Ingredient Sales Price (USD/MT) Forecast
Figure North America 2017-2022 Active Pharmaceutical Ingredient Consumption Volume (K MT) and Growth Rate Forecast
Figure China 2017-2022 Active Pharmaceutical Ingredient Consumption Volume (K MT) and Growth Rate Forecast
Figure Europe 2017-2022 Active Pharmaceutical Ingredient Consumption Volume (K MT) and Growth Rate Forecast
Figure Southeast Asia 2017-2022 Active Pharmaceutical Ingredient Consumption Volume (K MT) and Growth Rate Forecast
Figure Japan 2017-2022 Active Pharmaceutical Ingredient Consumption Volume (K MT) and Growth Rate Forecast
Figure India 2017-2022 Active Pharmaceutical Ingredient Consumption Volume (K MT) and Growth Rate Forecast
Table Global Sales Volume (K MT) of Active Pharmaceutical Ingredient by Type 2017-2022
Table Global Consumption Volume (K MT) of Active Pharmaceutical Ingredient by Application 2017-2022
Table Traders or Distributors with Contact Information of Active Pharmaceutical Ingredient by Region
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
